Literatur
-
1
Kornischka I, Cordes I, Angelink M W.
40 Jahre Betablocker in der Psychiatrie.
Fortschr Neurol Psychiat DOI: 10.1055/s-2006-944295.
-
2
Kohn R.
Beta-blockers an important cause of depression: a medical myth without evidence.
Med Health R I.
2001;
84
92-95
-
3
Head A, Kendall M J, Ferner R, Eagles C.
Acute effects of beta blockade and exercise on mood and anxiety.
Br J Sports Med.
1996;
30
238-242
-
4
Avorn J, Everitt D E, Weiss S.
Increased antidepressant use in patients prescribed beta-blockers.
JAMA.
1986;
255
357-360
-
5
Thiessen B Q, Wallace S M, Blackburn J L, Wilson T W, Bergman U.
Increased prescribing of antidepressants subsequent to beta-blocker therapy.
Arch Intern Med.
1990;
150
2286-2290
-
6
Lama P J.
Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment.
Am J Ophthalmol.
2002;
134
749-760
-
7
Ko D T, Hebert P R, Coffey C S, Sedrakyan A, Curtis J P, Krumholz H M.
Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction.
JAMA.
2002;
288
351-357
-
8
Bright R A, Everitt D E.
Beta-blockers and depression. Evidence against an association.
JAMA.
1992;
267
1783-1787
-
9
Gerstman B B, Jolson H M, Bauer M, Cho P, Livingston J M, Platt R.
The incidence of depression in new users of beta-blockers and selected antihypertensives.
J Clin Epidemiol.
1996;
49
809-815
-
10
Hallas J.
Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis.
Epidemiology.
1996;
7
478-484
-
11
Steffensmeier J J, Ernst M E, Kelly M, Hartz A J.
Do randomized controlled trials always trump case reports? A second look at propranolol and depression.
Pharmacotherapy.
2006;
26
162-167
Dr. med. Helge Frieling
Psychiatrische und Psychotherapeutische Klinik Universitätsklinikum Erlangen
Schwabachanlage 6
91054 Erlangen
eMail: helge.frieling@uk-erlangen.de
